ROBERT ZIMMERMAN: Open Payments
NPI 1689764706 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,949 in 21 payments from 5 companies in 2025. Trend: 2023 $14,693 · 2024 $13,229 · 2025 $5,949
Honoraria: $5,334Food & beverage: $500Education: $65Travel & lodging: $50
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 9 | $5,669 |
| Abbott Laboratories | 8 | $148 |
| Novo Nordisk Inc | 2 | $65 |
| Lilly USA, LLC | 1 | $35 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $32 |
Products named: GVOKE HYPOPEN, FREESTYLE LIBRE 3, MOUNJARO, Ozempic, Wegovy, SIGNIFOR LAR.
Industry payments across OH — which companies pay providers there.
